科研
教育
解决方案
登录
CN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Kathrin Brenker has not added Biography.
If you are Kathrin Brenker and would like to personalize this page please email our Author Liaison for assistance.
Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) mice.
Autoimmunity Feb, 2013 | Pubmed ID: 23039284
Max-Planck Institute for Immunobiology und Epigenetics
University of Freiburg
Kathrin Brenker1,2,3,
Kerstin Osthof1,4,
Jianying Yang1,3,
Michael Reth1,3,5
1, Max-Planck Institute for Immunobiology und Epigenetics,
2Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg,
3Centre for Biological Signaling Studies, BIOSS, University of Freiburg,
4, Albert-Ludwigs-Universität,
5Institute for Biology III (Mol. Immunology), Albert-Ludwigs-Universität
政策
使用条款
隐私
联系我们
向图书馆推荐
JoVE 新闻简报
JoVE Journal
技术专题合集
JoVE Encyclopedia of Experiments
档案
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教师资源中心
发表
图书馆员
访问权限
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有，本公司不涉及任何医疗业务和医疗服务。
